IBDEI135 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18124,2)
 ;;=^5007594
 ;;^UTILITY(U,$J,358.3,18125,0)
 ;;=I70.269^^94^903^9
 ;;^UTILITY(U,$J,358.3,18125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18125,1,3,0)
 ;;=3^Athscl Natv Arteries of Extrm w/ Gangrene,Unspec Extremity
 ;;^UTILITY(U,$J,358.3,18125,1,4,0)
 ;;=4^I70.269
 ;;^UTILITY(U,$J,358.3,18125,2)
 ;;=^5007607
 ;;^UTILITY(U,$J,358.3,18126,0)
 ;;=I70.263^^94^903^10
 ;;^UTILITY(U,$J,358.3,18126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18126,1,3,0)
 ;;=3^Athscl Natv Arteries of Extrm w/ Gangrene,Bilateral Legs
 ;;^UTILITY(U,$J,358.3,18126,1,4,0)
 ;;=4^I70.263
 ;;^UTILITY(U,$J,358.3,18126,2)
 ;;=^5007605
 ;;^UTILITY(U,$J,358.3,18127,0)
 ;;=I70.262^^94^903^11
 ;;^UTILITY(U,$J,358.3,18127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18127,1,3,0)
 ;;=3^Athscl Natv Arteries of Extrm w/ Gangrene,Left Leg
 ;;^UTILITY(U,$J,358.3,18127,1,4,0)
 ;;=4^I70.262
 ;;^UTILITY(U,$J,358.3,18127,2)
 ;;=^5007604
 ;;^UTILITY(U,$J,358.3,18128,0)
 ;;=I70.261^^94^903^12
 ;;^UTILITY(U,$J,358.3,18128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18128,1,3,0)
 ;;=3^Athscl Natv Arteries of Extrm w/ Gangrene,Right Leg
 ;;^UTILITY(U,$J,358.3,18128,1,4,0)
 ;;=4^I70.261
 ;;^UTILITY(U,$J,358.3,18128,2)
 ;;=^5007603
 ;;^UTILITY(U,$J,358.3,18129,0)
 ;;=I71.2^^94^903^20
 ;;^UTILITY(U,$J,358.3,18129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18129,1,3,0)
 ;;=3^Thoracic Aortic Aneurysm w/o Rupture
 ;;^UTILITY(U,$J,358.3,18129,1,4,0)
 ;;=4^I71.2
 ;;^UTILITY(U,$J,358.3,18129,2)
 ;;=^5007787
 ;;^UTILITY(U,$J,358.3,18130,0)
 ;;=I71.4^^94^903^1
 ;;^UTILITY(U,$J,358.3,18130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18130,1,3,0)
 ;;=3^Abdominal Aortic Aneurysm w/o Rupture
 ;;^UTILITY(U,$J,358.3,18130,1,4,0)
 ;;=4^I71.4
 ;;^UTILITY(U,$J,358.3,18130,2)
 ;;=^5007789
 ;;^UTILITY(U,$J,358.3,18131,0)
 ;;=I73.9^^94^903^19
 ;;^UTILITY(U,$J,358.3,18131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18131,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,18131,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,18131,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,18132,0)
 ;;=I82.891^^94^903^14
 ;;^UTILITY(U,$J,358.3,18132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18132,1,3,0)
 ;;=3^Embolism/Thrombosis Oth Spec Veins,Chronic
 ;;^UTILITY(U,$J,358.3,18132,1,4,0)
 ;;=4^I82.891
 ;;^UTILITY(U,$J,358.3,18132,2)
 ;;=^5007939
 ;;^UTILITY(U,$J,358.3,18133,0)
 ;;=I82.890^^94^903^13
 ;;^UTILITY(U,$J,358.3,18133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18133,1,3,0)
 ;;=3^Embolism/Thrombosis Oth Spec Veins,Acute
 ;;^UTILITY(U,$J,358.3,18133,1,4,0)
 ;;=4^I82.890
 ;;^UTILITY(U,$J,358.3,18133,2)
 ;;=^5007938
 ;;^UTILITY(U,$J,358.3,18134,0)
 ;;=E78.0^^94^904^12
 ;;^UTILITY(U,$J,358.3,18134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18134,1,3,0)
 ;;=3^Pure Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,18134,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,18134,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,18135,0)
 ;;=E78.1^^94^904^13
 ;;^UTILITY(U,$J,358.3,18135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18135,1,3,0)
 ;;=3^Pure Hyperglyceridemia
 ;;^UTILITY(U,$J,358.3,18135,1,4,0)
 ;;=4^E78.1
 ;;^UTILITY(U,$J,358.3,18135,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,18136,0)
 ;;=E78.2^^94^904^11
 ;;^UTILITY(U,$J,358.3,18136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18136,1,3,0)
 ;;=3^Mixed Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,18136,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,18136,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,18137,0)
 ;;=I10.^^94^904^3
 ;;^UTILITY(U,$J,358.3,18137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18137,1,3,0)
 ;;=3^Essential Primary Hypertension
